The mainstream media spent months ridiculing and discrediting Donald Trump for touting hydroxychloroquine as an effective therapy for COVID-19, but the findings of a new study may give Trump the last laugh.
The media relentlessly accused Trump of contributing to the virus’s death toll by pushing the controversial treatment — but a new study to be published in the December issue of the International Journal of Antimicrobial Agents found that the anti-malarial drug effectively reduces COVID-19 hospitalizations and mortality.
Dr. Vladimir Zelenko — along with two German doctors, Roland Derwand and Martin Scholz — conducted a study which sought to analyze the effectiveness of a triple-drug cocktail including hydroxychloroquine, a drug that’s been widely used for malaria and a number of other illnesses for decades.
Zelenko’s study analyzed the outcomes of COVID-19 patients treated with zinc, low-dose hydroxychloroquine, and azithromycin in the early stages of the disease. 141 patients received the antiviral cocktail of drugs and a control group of 377 patients did not.
The Blaze reported on Wednesday:
The study found that treated patients were 84% less likely to be hospitalized than untreated ones. Of 141 treated patients, four were hospitalized, which was significantly fewer than 58 of 377 untreated patients who were sent to the hospital. Additionally, the mortality rate for treated patients was lower. Only one patient in the treatment group died versus 13 patients in the untreated group. The patient who died had a history of cancer and only took one daily dose of the triple therapy before hospital admission.
A number of other studies conducted since the outset of the COVID-19 pandemic have returned mixed results in regard to the efficacy of hydroxychloroquine, but Zelenko pointed out that his study differs from many others because his study treated patients with the drug cocktail early in their diagnosis before serious or life-threatening symptoms set in.
“All studies that used HCQ with rather contradictory results were in hospitalized and often sicker patients,” the authors noted. Derwand added in a press release:
What differentiates this study is that patients were diagnosed very early with COVID-19 in an outpatient setting, and only high-risk patients were treated early on. Unfortunately, we seem to have forgotten common medical knowledge – that we want to treat any patient with an infectious disease as soon as possible. Dr. Zelenko treated his high-risk patients immediately with the three-drug regimen to ensure sufficient efficacy. He correctly didn’t wait for the disease to further develop.
Palmist — could be talking about Toobin https://t.co/pMmJmuv0kH
— Chuck Ross (@ChuckRossDC) November 26, 2020